Amgen, Inc. (AMGN)
377.35
-5.12
(-1.34%)
USD |
NASDAQ |
Sep 11, 16:00
377.81
+0.46
(+0.12%)
After-Hours: 20:00
Amgen Market Cap : 204.00B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 204.00B |
| September 10, 2026 | 206.76B |
| September 09, 2026 | 211.52B |
| September 08, 2026 | 212.55B |
| September 04, 2026 | 236.37B |
| September 03, 2026 | 240.09B |
| September 02, 2026 | 239.40B |
| September 01, 2026 | 236.85B |
| August 31, 2026 | 232.39B |
| August 28, 2026 | 233.77B |
| August 27, 2026 | 236.24B |
| August 26, 2026 | 238.05B |
| August 25, 2026 | 239.07B |
| August 24, 2026 | 239.94B |
| August 21, 2026 | 237.50B |
| August 20, 2026 | 234.47B |
| August 19, 2026 | 239.14B |
| August 18, 2026 | 229.91B |
| August 17, 2026 | 226.72B |
| August 14, 2026 | 224.46B |
| August 13, 2026 | 225.88B |
| August 12, 2026 | 224.99B |
| August 11, 2026 | 223.97B |
| August 10, 2026 | 225.54B |
| August 07, 2026 | 222.16B |
| Date | Value |
|---|---|
| August 06, 2026 | 218.86B |
| August 05, 2026 | 220.47B |
| August 04, 2026 | 210.84B |
| August 03, 2026 | 204.82B |
| July 31, 2026 | 208.22B |
| July 30, 2026 | 209.56B |
| July 29, 2026 | 209.56B |
| July 28, 2026 | 212.51B |
| July 27, 2026 | 203.41B |
| July 24, 2026 | 203.29B |
| July 23, 2026 | 200.83B |
| July 22, 2026 | 197.89B |
| July 21, 2026 | 197.99B |
| July 20, 2026 | 196.87B |
| July 17, 2026 | 198.02B |
| July 16, 2026 | 200.88B |
| July 15, 2026 | 193.71B |
| July 14, 2026 | 192.05B |
| July 13, 2026 | 194.86B |
| July 10, 2026 | 196.45B |
| July 09, 2026 | 196.57B |
| July 08, 2026 | 198.94B |
| July 07, 2026 | 198.99B |
| July 06, 2026 | 198.10B |
| July 02, 2026 | 202.27B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 178.36B |
| Regeneron Pharmaceuticals, Inc. | 80.81B |
| AbbVie, Inc. | 454.35B |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| Biogen, Inc. | 32.07B |
Market Cap Related Metrics
| PE Ratio | 23.44 |
| PS Ratio | 5.366 |
| PEG Ratio | 0.7394 |
| Price to Book Value | 17.45 |
| Price to Free Cash Flow | 20.15 |
| Price | 377.35 |
| Earnings Yield | 4.27% |
| PEGY Ratio | 0.6827 |
| Operating PE Ratio | 16.11 |
| Normalized PE Ratio | 21.39 |